danielraymond's library 94 articles Export

Ordered by to_read.

	Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. [My Copy] Clin Infect Dis, Vol. 40 Suppl 5 (15 April 2005) by S. A. Strathdee, M. Latka, J. Campbell, et al.P. T. O'Driscoll, E. T. Golub, F. Kapadia, R. A. Pollini, R. S. Garfein, D. L. Thomas, H. Hagan, posted to hcv health idu interferon treatment young by danielraymond on 2005-07-16 06:33:38 as
	Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. [My Copy] Addiction, Vol. 99, No. 5. (May 2004), pp. 621-633. by T. Rhodes, M. Davis, A. Judd posted to hcv idu knowledge prevention qualitative risk sharing by danielraymond on 2005-07-16 06:05:06 as
	Anthropological insights into the use of race/ethnicity to explore genetic contributions to disparities in health. [My Copy] J Biosoc Sci, Vol. 38, No. 1. (January 2006), pp. 83-102. by S. M. Outram, G. T. Ellison posted to disparities genetics race by danielraymond on 2006-06-23 17:22:50 as along with 1 person and 1 group cgreal CGREL
	Controlled drinking, harm reduction and their roles in the response to alcohol-related problems [My Copy] Addiction Research and Theory, Vol. 14, No. 1. (February 2006), pp. 7-18. by Nick Heather posted to alcohol controlled-drinking harm-reduction moderation by danielraymond on 2006-06-23 16:55:31 as along with 1 person docalex
	Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis [My Copy] Journal of Viral Hepatitis, Vol. 12, No. 6. (November 2005), pp. 655-662. by A. Judd, S. Hutchinson, S. Wadd, et al.M. Hickman, A. Taylor, S. Jones, J. V. Parry, S. Cameron, T. Rhodes, S. Ahmed, S. Bird, R. Fox, A. Renton, G. V. Stimson, D. Goldberg posted to hcv idu prevalence risk by danielraymond on 2005-11-08 13:58:11 as along with 1 person norahpalmateer
	Viral evolution of hepatitis C in injection drug users [My Copy] Journal of Viral Hepatitis, Vol. 12, No. 6. (November 2005), pp. 574-583. by L. Dove, Y. Phung, N. Bzowej, M. Kim, A. Monto, T. L. Wright posted to hcv idu quasispecies reinfection by danielraymond on 2005-11-08 13:54:41 as
	Intrahepatic CD8(+) T-cell failure during chronic hepatitis C virus infection. [My Copy] Hepatology, Vol. 42, No. 4. (October 2005), pp. 828-837. by H. C. Spangenberg, S. Viazov, N. Kersting, et al.C. Neumann-Haefelin, D. McKinney, M. Roggendorf, F. von Weizsäcker, H. E. Blum, R. Thimme posted to cd8 chronic hcv intrahepatic by danielraymond on 2005-09-27 14:12:40 as
	Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994--1996. [My Copy] Subst Use Misuse, Vol. 40, No. 1. (2005), pp. 63-76. by D. Huo, S. L. Bailey, R. S. Garfein, L. J. Ouellet posted to chicago cooker hiv idu sep sharing syringe by danielraymond on 2005-09-04 19:23:00 as
	Guarding against threatening HIV prevention messages: an information-processing model. [My Copy] Health Educ Behav, Vol. 27, No. 6. (December 2000), pp. 780-795. by S. J. Blumberg posted to hiv messages prevention by danielraymond on 2005-09-04 18:44:12 as
	Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico. [My Copy] Int J Epidemiol, Vol. 34, No. 3. (June 2005), pp. 593-599. by C. M. Pérez, E. Suárez, E. A. Torres, K. Román, V. Colón posted to hcv prevalence puertorico risk by danielraymond on 2005-07-16 05:21:28 as
	Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. [My Copy] Eur Addict Res, Vol. 7, No. 1. (March 2001), pp. 40-45. by J. P. Moatti, D. Vlahov, I. Feroni, V. Perrin, Y. Obadia posted to idu pharmacy sep syringe by danielraymond on 2005-07-16 04:58:29 as
	Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. [My Copy] Hepatology, Vol. 42, No. 1. (16 June 2005), pp. 104-112. by Andrea L L. Cox, Timothy Mosbruger, Georg M M. Lauer, Drew Pardoll, David L L. Thomas, Stuart C C. Ray posted to acute cd8 epitopes hcv by danielraymond on 2005-06-20 13:10:55 as
	Injecting shared drugs: an observational study of the process of drug acquisition, preparation, and injection by Puerto Rican drug users. [My Copy] J Psychoactive Drugs, Vol. 37, No. 1. (March 2005), pp. 37-49. by H. A. Finlinson, H. M. Colón, M. S. López, R. R. Robles, J. G. Cant posted to hcv hiv idu prevention by danielraymond on 2005-05-30 20:24:56 as
	Duration of peginterferon therapy in acute hepatitis C: a randomized trial. [My Copy] Hepatology, Vol. 43, No. 5. (May 2006), pp. 923-931. by S. M. Kamal, K. N. Moustafa, J. Chen, et al.J. Fehr, A. Abdel Moneim, K. E. Khalifa, L. A. El Gohary, A. H. Ramy, M. A. Madwar, J. Rasenack, N. H. Afdhal posted to acute duration hcv treatment by danielraymond on 2006-06-23 18:00:14 as
	Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. [My Copy] Gastroenterology, Vol. 130, No. 3. (March 2006), pp. 632-638. by S. M. Kamal, A. E. Fouly, R. R. Kamel, et al.B. Hockenjos, A. Al Tawil, K. E. Khalifa, Q. He, M. J. Koziel, K. M. El Naggar, J. Rasenack, N. H. Afdhal posted to acute hcv onset treatment by danielraymond on 2006-06-23 17:59:35 as
	VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cells. [My Copy] Antimicrob Agents Chemother, Vol. 50, No. 5. (May 2006), pp. 1813-1822. by K. Lin, R. B. Perni, A. D. Kwong, C. Lin posted to hcv protease-inhibitor vx-950 by danielraymond on 2006-06-23 17:58:22 as along with 1 person mccownm
	Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease. [My Copy] Antimicrob Agents Chemother, Vol. 50, No. 3. (March 2006), pp. 899-909. by R. B. Perni, S. J. Almquist, R. A. Byrn, et al.G. Chandorkar, P. R. Chaturvedi, L. F. Courtney, C. J. Decker, K. Dinehart, C. A. Gates, S. L. Harbeson, A. Heiser, G. Kalkeri, E. Kolaczkowski, K. Lin, Y. P. Luong, B. G. Rao, W. P. Taylor, J. A. Thomson, R. D. Tung, Y. Wei, A. D. Kwong, C. Lin posted to hcv protease-inhibitor vx-950 by danielraymond on 2006-06-23 17:57:45 as along with 1 person josealonsoneto
	Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034. [My Copy] Antiviral Res, Vol. 70, No. 2. (June 2006), pp. 28-38. by X. Tong, R. Chase, A. Skelton, T. Chen, J. Wright-Minogue, B. A. Malcolm posted to hcv protease-inhibitor resistance sch-503034 by danielraymond on 2006-06-23 17:56:56 as
	Providers' HIV Prevention Discussions with HIV-Seropositive Injection Drug Users. [My Copy] AIDS Behav (26 April 2006) by James D. Wilkinson, Wei Zhao, Scott Santibanez, et al.Julia Arnsten, Amy Knowlton, Cynthia A. Gómez, Lisa R. Metsch, posted to hiv idu prevention by danielraymond on 2006-06-23 16:28:40 as
	Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In Vivo [My Copy] J. Virol., Vol. 80, No. 5. (1 March 2006), pp. 2280-2290. by Sampa Pal, Margaret C. Shuhart, Lisa Thomassen, et al.Scott S. Emerson, Tao Su, Nathan Feuerborn, John Kae, David R. Gretch posted to hcv hiv intrehepatic replication by danielraymond on 2006-02-11 19:45:53 as
	Accumulation of dysfunctional effector CD8+T cells in the liver of patients with chronic HCV infection. [My Copy] J Hepatol (5 December 2005) by Carla Nisii, Massimo Tempestilli, Chiara Agrati, et al.Fabrizio Poccia, Guido Tocci, Maria Antonella A. Longo, Gianpiero D'Offizi, Roberto Tersigni, Oreste Lo L. Iacono, Giorgio Antonucci, Alessandra Oliva posted to cd8 dysfunction hcv by danielraymond on 2006-01-29 17:47:29 as
	Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. [My Copy] Ethn Dis, Vol. 14, No. 4. (2004), pp. 589-596. by C. M. Fuller, S. Galea, S. Blaney, et al.D. C. Ompad, S. Deren, D. Des Jarlais, D. Vlahov posted to idu pharmacy race syringe by danielraymond on 2005-11-20 20:32:41 as
	HIV among injection drug users in large US metropolitan areas, 1998. [My Copy] J Urban Health, Vol. 82, No. 3. (September 2005), pp. 434-445. by S. R. Friedman, S. Lieb, B. Tempalski, et al.H. Cooper, M. Keem, R. Friedman, P. L. Flom posted to hiv idu by danielraymond on 2005-11-20 20:29:06 as
	Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection. [My Copy] AIDS Res Hum Retroviruses, Vol. 21, No. 9. (September 2005), pp. 743-752. by A. Mocroft, A. N. Phillips, V. Soriano, et al.J. Rockstroh, A. Blaxhult, C. Katlama, A. Boron-Kaczmarska, L. Viksna, O. Kirk, J. D. Lundgren posted to discontinuation haart hcv hiv toxicity by danielraymond on 2005-10-18 12:10:01 as
	Sexual Risk Behavior Among Injection Drug Users Before Widespread Availability of Highly Active Antiretroviral Therapy. [My Copy] AIDS Behav (18 August 2005), pp. 1-11. by Melanie L. Rusch, Homayoon Farzadegan, Patrick M. Tarwater, Mahboobeh Safaeian, David Vlahov, Steffanie A. Strathdee posted to haart hiv idu risk sex by danielraymond on 2005-09-04 17:45:26 as
	Keeping it together: Stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents. [My Copy] AIDS Care, Vol. 17, No. 7. (October 2005), pp. 802-813. by P. Mateu-Gelabert, C. Maslow, P. L. Flom, M. Sandoval, M. Bolyard, S. R. Friedman posted to community crack idu risk social by danielraymond on 2005-09-04 17:44:57 as
	More Severe Parenchymal Injury in Chronic Hepatitis C Acquired by Recent Injection Drug Use. [My Copy] J Clin Gastroenterol, Vol. 39, No. 8. (September 2005), pp. 722-727. by Matthew M. Yeh, Zelma J. Buskell, Leonard B. Seeff, Doris Strader, Elizabeth C. Wright, Zachary D. Goodman posted to fibrosis hcv idu by danielraymond on 2005-09-04 16:50:46 as
	Updating the infection risk reduction hierarchy: preventing transition into injection. [My Copy] J Urban Health, Vol. 81, No. 1. (March 2004), pp. 14-19. by D. Vlahov, C. M. Fuller, D. C. Ompad, S. Galea, D. C. Des Jarlais posted to hcv idu initiation risk by danielraymond on 2005-07-16 06:31:28 as
	Liver enzyme values in injection drug users with chronic hepatitis C. [My Copy] Dig Liver Dis (9 June 2005) by S H H. Mehta, D Netski, M S S. Sulkowski, S A A. Strathdee, D Vlahov, D L L. Thomas posted to alt hcv idu uln by danielraymond on 2005-07-16 06:12:10 as
	Injection frequency mediates health service use among persons with a history of drug injection. [My Copy] Drug Alcohol Depend, Vol. 70, No. 2. (21 May 2003), pp. 159-168. by M. D. Stein, B. Anderson posted to er health idu methadone by danielraymond on 2005-07-16 04:54:00 as
	An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies. [My Copy] J Virol, Vol. 79, No. 13. (July 2005), pp. 8217-8229. by B. Bartosch, G. Verney, M. Dreux, et al.P. Donot, Y. Morice, F. Penin, J. M. Pawlotsky, D. Lavillette, F. L. Cosset posted to envelope hcv hcvpp hdl hvr1 sr-bi by danielraymond on 2005-06-20 13:25:31 as
	High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. [My Copy] Gastroenterology, Vol. 127, No. 3. (September 2004), pp. 924-936. by G. M. Lauer, E. Barnes, M. Lucas, et al.J. Timm, K. Ouchi, A. Y. Kim, C. L. Day, G. K. Robbins, D. R. Casson, M. Reiser, G. Dusheiko, T. M. Allen, R. T. Chung, B. D. Walker, P. Klenerman posted to acute cd8 chronic hcv hla by danielraymond on 2005-06-20 13:16:26 as along with 1 person ernestbrons
	Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. [My Copy] Addiction, Vol. 97, No. 10. (October 2002), pp. 1277-1287. by R. Heimer, S. Clair, L. E. Grau, R. N. Bluthenthal, P. A. Marshall, M. Singer posted to hcv hiv idu knowledge risk by danielraymond on 2005-05-31 23:07:17 as along with 1 person norahpalmateer
	Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. [My Copy] Int J Epidemiol, Vol. 34, No. 1. (February 2005), pp. 121-130. by C. Lewden, D. Salmon, P. Morlat, et al.S. Bévilacqua, E. Jougla, F. Bonnet, L. Héripret, D. Costagliola, T. May, G. Chêne, posted to haart hcv hiv mortality by danielraymond on 2006-09-21 19:03:26 as along with 1 person markpoliz
	Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users. [My Copy] Epidemiol Infect (17 May 2006), pp. 1-7. by J Amin, M G G. Law, J Micallef, et al.M Jauncey, I VAN Beek, J M M. Kaldor, G J J. Dore posted to acute clearance hcv idu by danielraymond on 2006-09-21 18:56:32 as
	Compliance/Adherence, HIV, and the Critique of Medical Power [My Copy] Social Theory & Health, Vol. 2, No. 4., 315. by Eric Mykhalovskiy, Liza Mccoy, Michael Bresalier posted to adherence foucault hiv power by danielraymond on 2006-09-11 21:51:43 as along with 1 person zhlobko
	The expert patient: Illness as practice [My Copy] Medicine, Health Care and Philosophy, Vol. 8, No. 2. (January 2005), pp. 165-171. by Andrew Edgar posted to expertise by danielraymond on 2006-07-05 21:23:41 as along with 1 person docalex
	Care of the Self and Patient Participation in Genetic Discourse: A Foucauldian Reading of the Surgeon General's My Family Health Portrait Program [My Copy] Journal of Genetic Counseling, Vol. 14, No. 6. (December 2005), pp. 423-434. by Benjamin Bates posted to foucault genetics by danielraymond on 2006-07-05 20:34:20 as
	Therapeutic misconception and the appreciation of risks in clinical trials. [My Copy] Soc Sci Med, Vol. 58, No. 9. (May 2004), pp. 1689-1697. by C. W. Lidz, P. S. Appelbaum, T. Grisso, M. Renaud posted to clinical-trials therapeutic-misconception by danielraymond on 2006-06-23 17:56:05 as
	Letting the Gini out of the bottle? Challenges facing the relative income hypothesis. [My Copy] Soc Sci Med, Vol. 54, No. 4. (February 2002), pp. 561-576. by G. T. Ellison posted to income-inequality relative-income ses by danielraymond on 2006-06-23 17:48:08 as
	Amphetamine users in Amsterdam: Patterns of use and modes of self-regulation [My Copy] Addiction Research and Theory, Vol. 14, No. 2. (April 2006), pp. 159-188. by Uitermark, Justus, Cohen, D. A. Peter posted to amphetamine amsterdam self-regulation by danielraymond on 2006-06-23 16:53:48 as
	Behavioural self-management with problem drinkers: One-year follow-up of a controlled drinking group treatment approach [My Copy] Addiction Research and Theory, Vol. 14, No. 1. (February 2006), pp. 35-49. by Joachim Koerkel posted to alcohol moderation by danielraymond on 2006-06-23 16:39:51 as along with 2 people docalex craigtalbert
	Obstacles to the adoption of low risk drinking goals in the treatment of alcohol problems in the United States: A commentary [My Copy] Addiction Research and Theory, Vol. 14, No. 1. (February 2006), pp. 19-24. by Mark B. Sobell, Linda C. Sobell posted to alcohol moderation by danielraymond on 2006-06-23 16:36:51 as along with 1 person docalex
	Associations Between Substance Use and Sexual Risk Among Very Young Men Who Have Sex With Men. [My Copy] Sex Transm Dis, Vol. Publish Ahead of Print (13 January 2006) by David D. Celentano, Linda A. Valleroy, Frangiscos Sifakis, et al.Duncan A. Mackellar, John Hylton, Hanne Thiede, Willi McFarland, Douglas A. Shehan, Susan R. Stoyanoff, Marlene Lalota, Beryl A. Koblin, Mitchell H. Katz, Lucia V. Torian, posted to drugs msm risk sex by danielraymond on 2006-02-04 21:50:32 as
	Relation between viral fitness and immune escape within the hepatitis C virus protease. [My Copy] Gut, Vol. 55, No. 2. (February 2006), pp. 266-274. by J. Söderholm, G. Ahlén, A. Kaul, et al.L. Frelin, M. Alheim, C. Barnfield, P. Liljeström, O. Weiland, D. R. Milich, R. Bartenschlager, M. Sällberg posted to cd8 epitopes escape fitness hcv by danielraymond on 2006-01-29 19:02:02 as
	Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes [My Copy] Journal of Viral Hepatitis, Vol. 13, No. 2. (February 2006), pp. 121-130. by H. Komatsu, G. Lauer, O. G. Pybus, et al.K. Ouchi, D. Wong, S. Ward, B. Walker, P. Klenerman posted to cd8 epitopes escape hcv by danielraymond on 2006-01-29 18:45:11 as
	Ethnic differences in the presentation of chronic hepatitis C [My Copy] Journal of Viral Hepatitis, Vol. 13, No. 2. (February 2006), pp. 116-120. by R. Lepe, J. E. Layden-Almer, T. J. Layden, S. Cotler posted to hcv latino by danielraymond on 2006-01-29 18:42:27 as
	Hepatitis C and steatosis: a reappraisal [My Copy] Journal of Viral Hepatitis, Vol. 13, No. 2. (February 2006), pp. 73-80. by A. Lonardo, P. Loria, L. E. Adinolfi, N. Carulli, G. Ruggiero posted to hcv steatosis by danielraymond on 2006-01-29 17:58:15 as
	Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI). [My Copy] J Hepatol (20 December 2005) by Marianne Maynard, Pierre Pradat, François Bailly, et al.Frédéric Rozier, Chantal Nemoz, Si Nafa Si N. Ahmed, Patrice Adeleine, Christian Trepo, And A French Multicenter Group posted to amantadine hcv non-responder by danielraymond on 2006-01-29 17:45:35 as
	Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. [My Copy] Hepatology, Vol. 43, No. 1. (January 2006), pp. 100-107. by G. Raimondo, M. R. Brunetto, P. Pontisso, et al.A. Smedile, A. M. Maina, C. Saitta, G. Squadrito, N. Tono, posted to coinfection hbv hcv hdv by danielraymond on 2006-01-29 17:34:51 as

Note: You may cite this page as: http://www.citeulike.org/user/danielraymond/order/to_read

Result page: 1 2 Next

hcv	42
idu	36
hiv	32
risk	16
msm	7
acute	6
cd8	6
health	5
prevention	5
soc	5
ttm	5
epidemiology	4
sep	4
sex	4
syringe	4
treatment	4
alcohol	3
cocaine	3
drugs	3
epitopes	3
escape	3
haart	3
methamphetamine	3
moderation	3
pharmacy	3
prevalence	3
protease-inhibitor	3
seroconversion	3
social	3
chronic	2
er	2
fitness	2
foucault	2
genetics	2
interferon	2
knowledge	2
methadone	2
narrative	2
quasispecies	2
race	2
replication	2
sharing	2
sr-bi	2
theory	2
vx-950	2
access	1
actimmune	1
adherence	1
alt	1
amantadine	1
amphetamine	1
amsterdam	1
anemia	1
behavior	1
cambodia	1
cd81	1
cessation	1
chicago	1
clearance	1
clinical-trials	1
coinfection	1
community	1
controlled-drinking	1
cooker	1
crack	1
cultural	1
debi	1
discontinuation	1
disparities	1
duration	1
dysfunction	1
efficacy	1
entry	1
envelope	1
ethnography	1
evolution	1
exosome	1
expertise	1
fear	1
fibrosis	1
frequency	1
harm-reduction	1
hav	1
hbt	1
hbv	1
hcvpp	1
hdl	1
hdv	1
heroin	1
hhrp	1
hla	1
hospital	1
housing	1
hur	1
hvr1	1
impulsivity	1
income-inequality	1
inhaler	1
initiation	1
interventions	1
intrahepatic	1
intravention	1
intrehepatic	1
latino	1
ldl-r	1
legal	1
lipids	1
local	1
messages	1
mexico	1
mitochondria	1
mortality	1
networks	1
non-responder	1
onset	1
partner_notification	1
pbmc	1
policy	1
polydrug	1
power	1
psma7	1
puertorico	1
qualitative	1
raceethnicity	1
reinfection	1
relative-income	1
replicon	1
resistance	1
ribavirin	1
riskreduction	1
satx	1
sch-503034	1
self-regulation	1
ses	1
sexworker	1
sf	1
sirna	1
socialmarketing	1
std	1
steatosis	1
stigma	1
structural	1
therapeutic-misconception	1
toxicity	1
uln	1
vaccine	1
valeant	1
viramidine	1
young	1

danielraymond's library 94 articles Export

danielraymond's tags